A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
That means compounded versions of semaglutide – the active ingredient in Novo Nordisk's Ozempic and Rybelsus for diabetes and obesity therapy Wegovy – are already in the market. While Novo ...
Under US law, compounding pharmacies can make and sell ... of tirzepatide and other obesity therapies like Novo Nordisk's Wegovy (semaglutide), which remains on the shortages list.